Anthropic has warned that recursive-self-improving AI could be on the horizon, but the truth is the company is more ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Of all the reasons Python is a hit with developers, one of the biggest is its broad and ever-expanding selection of third-party packages. Convenient toolkits for everything from ingesting and ...

Artificial intelligence (AI) may not be building better versions of itself yet, but Anthropic says the world is moving closer to that possibility than many people realize. In a new research paper ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The HBO series’ third season always felt like a wild tonal shift away from the previous two ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...

CEO Jensen Huang reiterated what he has been saying out loud all this time, although this time his words were a little bit ...